Literature DB >> 22456609

Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.

Sarah L Kenny1, Hilary A McBride, Jackie Jamison, W Glenn McCluggage.   

Abstract

Mesonephric adenocarcinomas are rare neoplasms that most commonly arise in the uterine cervix and exceptionally rarely in the uterine corpus. Although the morphologic features of these neoplasms are well described, there has been relatively limited investigation of the immunoprofile. We report a series of 8 mesonephric adenocarcinomas arising in the uterine cervix (7 cases) and corpus (1 case) and undertake a comprehensive immunohistochemical analysis. This includes markers that have not been investigated previously in mesonephric adenocarcinomas but that are commonly used in gynecologic pathology and may be undertaken when other, mainly Mullerian, adenocarcinomas are considered in the differential diagnosis. Linear array human papillomavirus (HPV) genotyping was also performed. Our results broadly confirm the immunohistochemical profile demonstrated in previous studies with the majority of mesonephric adenocarcinomas staining positively with CD10 (6 of 8), epithelial membrane antigen (8 of 8), vimentin (8 of 8), and calretinin (7 of 8). Estrogen receptor was positive in 2, carcinoembryonic antigen in 3, and inhibin in 4 cases. p16 was positive in 5 cases (1 diffuse and strong), despite all being HPV negative (in 1 case, there was insufficient DNA for HPV analysis). Novel findings in our study were the demonstration of nuclear positivity with PAX8 and HMGA2 in 7 cases, CA125 immunoreactivity in all 8 cases, and TTF1 and hepatocyte nuclear factor 1-β staining in 3 cases. As PAX8, CA125, HMGA2, and hepatocyte nuclear factor 1-β are commonly positive in a variety of Mullerian adenocarcinomas arising in the female genital tract, this may result in diagnostic confusion. All cases were WT1 negative.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456609     DOI: 10.1097/PAS.0b013e31824a72c6

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  38 in total

1.  Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.

Authors:  Jia Liu; Su Dong; Heather Wang; Lian Li; Qinmao Ye; Yanhui Li; Jiaxing Miao; Sissy Jhiang; Jing Zhao; Yutong Zhao
Journal:  FASEB J       Date:  2019-06-25       Impact factor: 5.191

2.  Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Authors:  Oluwole Fadare; Vinita Parkash; Katja Gwin; Krisztina Z Hanley; Elke A Jarboe; Sharon X Liang; Charles M Quick; Wenxin Zheng; Kojo R Rawish; Jonathan L Hecht; Mohamed M Desouki
Journal:  Hum Pathol       Date:  2013-10-10       Impact factor: 3.466

Review 3.  The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Authors:  Maria Rosaria Raspollini; Sigurd F Lax; W Glenn McCluggage
Journal:  Virchows Arch       Date:  2018-05-24       Impact factor: 4.064

4.  A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.

Authors:  Patrice Desmeules; Philippe Joubert; Lei Zhang; Hikmat A Al-Ahmadie; Christopher D Fletcher; Efsevia Vakiani; Deborah F Delair; Natasha Rekhtman; Marc Ladanyi; William D Travis; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

Review 5.  Recent advances in invasive adenocarcinoma of the cervix.

Authors:  Simona Stolnicu; Lien Hoang; Robert A Soslow
Journal:  Virchows Arch       Date:  2019-06-17       Impact factor: 4.064

6.  Mesonephric adenocarcinoma of the uterine corpus.

Authors:  Haixia Wu; Lin Zhang; Wenfeng Cao; Yuanjing Hu; Yixin Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

7.  International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

8.  Fallopian Tube Mucosal Involvement in Cervical Gastric-type Adenocarcinomas: Report of a Series With Discussion of the Distinction From Synchronous In Situ Tubal Lesions.

Authors:  Simon Rajendran; Yaser Hussein; Kay J Park; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

9.  Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases.

Authors:  Oluwole Fadare; Wenxin Zheng; Marta A Crispens; Howard W Iii Jones; Dineo Khabele; Katja Gwin; Sharon X Liang; Khaled Mohammed; Mohamed M Desouki; Vinita Parkash; Jonathan L Hecht
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

10.  Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.

Authors:  Jelena Mirkovic; Lynette M Sholl; Elizabeth Garcia; Neal Lindeman; Laura MacConaill; Michelle Hirsch; Paola Dal Cin; Melissa Gorman; Justine A Barletta; Marisa R Nucci; W Glenn McCluggage; Brooke E Howitt
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.